Drug Side Effects
Search
HEPATIC HYPERTROPHY
HEPATIC HYPERTROPHY
was reported 32 times
HEPATIC HYPERTROPHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC]
3
0.0009
1
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
1
0.0001
2
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
2
0.0001
3
Lipid-based Polyene Antifungal [EPC]
1
0.0001
4
CTLA-4-directed Blocking Antibody [EPC]
2
0.0000
5
Programmed Death Receptor-1 Blocking Antibody [EPC]
4
0.0000
6
Antirheumatic Agent [EPC]
4
0.0000
7
Nucleoside Analog Antiviral [EPC]
3
0.0000
8
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
3
0.0000
9
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
3
0.0000
10
Polyene Antifungal [EPC]
1
0.0000
11
Estrogen Receptor Antagonist [EPC]
1
0.0000
12
Epidermal Growth Factor Receptor Antagonist [EPC]
1
0.0000
13
Azole Antifungal [EPC]
3
0.0000
14
Aromatase Inhibitor [EPC]
2
0.0000
15
Partial Opioid Agonist [EPC]
1
0.0000
16
Purine Antimetabolite [EPC]
1
0.0000
17
5-alpha Reductase Inhibitor [EPC]
1
0.0000
18
Vitamin C [EPC]
4
0.0000
19
HMG-CoA Reductase Inhibitor [EPC]
3
0.0000
20
Opioid Agonist [EPC]
2
0.0000
21
Platinum-based Drug [EPC]
2
0.0000
22
Estrogen [EPC]
1
0.0000
23
Endothelin Receptor Antagonist [EPC]
1
0.0000
24
Atypical Antipsychotic [EPC]
2
0.0000
25
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
26
Corticosteroid [EPC]
3
0.0000
27
Loop Diuretic [EPC]
1
0.0000
28
Kinase Inhibitor [EPC]
1
0.0000
29
Nonsteroidal Anti-inflammatory Drug [EPC]
2
0.0000
30
Tumor Necrosis Factor Blocker [EPC]
1
0.0000